TP53 and breast carcinoma: Direct loss, expression imbalance, or abnormal function of DDR proteins (TP53, BRCA1, ATM, etc.)all increase the risk of breast cancer, the occurrence of malignant subtypes, and the chemotherapy resistance of tumors.